Clinical application of the PKG® system

The PKG® provides objective, ambulatory, continuous assessment of motor complications associated with movement disorders including:

  •  Assessment of bradykinesia, dyskinesia and tremor
  •  Ability to correlate symptom fluctuations and their severity with respect to levodopa dosage
  •  Self-reported levodopa compliance
  •  A record of daytime sleepiness and immobility
  •  Assessment of the risk of Impulse Control Disorders

An example of a PKG® main plot showing Dyskinesia Score (DKS) in green and Bradykinesia Score (BKS) in blue

Assessment with a PKG® can be useful in:

  •  Establishing a symptomology baseline and monitoring response to treatment
  •  Confirming an intervention has worked and guiding therapy optimisation
  •  Discovering “off” times with current therapy
  •  Establishing whether an advanced therapy should be considered
  •  Identifying non-motor symptoms of Parkinson’s Disease such as sleep and risk of ICD
  •  Obtaining a comprehensive initial patient history